and 2-amino-1-methyl-6-phenylimidazo [4,5-b] transition zone makes up only 5% of the total volume of tissues (mean, 1/10 8 ). The CYP1 inhibitor α-naphthoflavone the prostate, but may account for 90% of a benignly enlarged (10 µM) reduced B[a]P-DNA adduct formation in tissues prostate. In most cases, increases in prostatic volume are due from two individuals by 96 and 64%, respectively. This pilot to hyperplasia (20). The incidence of prostate cancer is highest study shows that human prostate tissue can metabolically in those countries with a high risk of developing BPH (20). activate 'cooked meat' carcinogens, a process that could
Introduction ary report of our findings has appeared in abstract form (21) . The World Health Organization lists meat and animal fat intake as known risk factors for the development of prostate cancer Materials and methods (1). A high intake of 'well done' cooked meat has also recently Olympus 27 Ch resectoscope with continuous balanced irrigation of the bladder using aqueous glycine (1.5% w/v) and resection was by pure cut diathermy using a Valleylab Force 2 generator at 165 W pure cutting current. Tissues were immediately placed in cold HEPES-buffered saline (HBS) buffer in sterile vessels (23) . A sliver from each sample was removed to confirm the histology by conventional light microscopy. Within 4 h, tissues were either frozen for subsequent gene expression analysis and stored at Ϫ70°C or transferred from the collection vessels, rinsed in fresh cold HBS and placed in sterile vials containing 'growth' medium (medium PFMR-4A) as described previously (23) .
Analysis of gene expression by RT-PCR
Tissues from four selected individuals (HP3 and HP6, HP7 and HP8) were investigated for expression of CYP1A1, CYP1A2 and CYP1B1 genes, using β-actin gene expression for comparison, according to a previously published method (8) . Positive controls for CYP1A1 and CYP1B1 were derived from Fig. 1 . RT-PCR analysis of CYP1A1, CYP1A2 and CYP1B1 expression in benz [a] anthracene-treated human mammary epithelial cells (8) , and the positive human prostatic tissue. PCR products were derived from reverse-transcribed control for the CYP1A2 gene was derived from human liver [a gift from Dr mRNA from BPH tissues (n ϭ 4). PCR products were detected after Alastair Strain, University of Birmingham, UK (8) ]. Levels of the CYP1 electrophoresis (100 V, 60 min) with UV illumination of an ethidium mRNA transcripts of interest were expressed as a ratio of the level of β-actin bromide stained gel. mRNA transcripts as standard units, from a single sample of cDNA. Negative (no cDNA) and positive controls were used for each amplification reaction. The sizes of the PCR products were: CYP1A1, 146 bp; CYP1A2, 243 bp; CYP1B1, 489 bp; and β-actin, 661 bp. Analyser. Aliquots (60 µl) were separated on a Phenomenex 250ϫ4.6 mm 5µ proteinase K digestion (2 mg/ml for 2 h at 37°C) before DNA isolation (24) .
C 18 Jupiter Column using a two-solvent system. Solvent A was ammonium 32 P-postlabelling of DNA adducts and HPLC analysis formate (2 M, pH 4.0) and solvent B was a 6:1 v/v mixture of acetonitrile and methanol. The gradient was 10-30% solvent B for 70 min, followed by DNA adduct analysis was carried out on 4 µg DNA for each sample. The 30-50% solvent B for 10 min. The flow rate was 1 ml/min. 32 P-postlabelling method employed for measurement of heterocyclic amine-DNA adducts was using the ATP-deficient conditions described by Hall et al. (25) . Further enzymatic digestion of the 32 P-postlabelled mixture of mono-,
Results
di-and oligonucleotide 3Ј,5Ј-bisphosphates was carried out to produce 5Ј-
CYP gene expression in BPH tissues
mononucleotide adducts as described by Ochiai (26) . The nuclease P1 method was employed for analysis of B[a]P-DNA adducts (27) . 32 P-postlabelling in the current study is, however, too low to make definitive the activity of O-esterification enzymes, for example NATs conclusions about co-ordinate regulation of CYP1 genes in and SULTs, than for the enzymes that catalyse PhIP Nthis tissue.
hydroxylation. IQ-DNA adducts were detectable (Table I phosphates gave rise to a major adduct spot 1 (Figure 2e ) was 900-fold higher compared with tissues incubated with the which constituted 88 and 94% (Figure 2f ) of the total radioparent compound PhIP (3 adducts per 10 8 nucleotides). Our activity, respectively. HPLC analysis of adduct spot 1 derived results suggest that the enzymes catalysing N-hydroxylation from N-hydroxy PhIP and the PhIP-DNA standard showed enzymes are rate limiting in PhIP-DNA adduct formation in that these radioactive peaks co-eluted at 44 min (not shown). these prostatic tissues. The greater variation between This strongly indicates the identity of the adduct formed in individuals for metabolic activation of N-hydroxy-PhIP compared with PhIP, suggests larger inter-individual differences in prostatic tissues as N-(deoxyguanosin-8-yl)-2-amino-1-methyl- inhibition, 80%).
Metabolic activation of benzo[a]pyrene by prostatic tissues in
c Adducts in DNA from individuals HP2 and HP3 were analysed in triplicate.
Influence of prostatectomy method on adduct formation
On the basis of a limited number of experiments, our results show that there are no differences in the abilities of tissues obtained from open radical prostatectomy and those obtained by transurethral prostatectomy using hot wire diathermy to metabolically activate IQ and B[a]P. Both methods of prostatectomy therefore seem to be suitable for providing tissues for carcinogen metabolism studies.
Discussion
Gene expression analysis of cDNAs from four individuals detected the expression of CYP1A1, CYP1A2 and CYP1B1 genes in BPH tissues. The expression of CYP1A2 was originally thought to be confined to the liver (30) and is barely detectable in cultured human mammary epithelial cells derived from reduction mammoplasty tissues (8), but has been detected CYP1A2 is not expressed (7) . CYP1A2 has 30 times (and CYP1A1 80 times) the catalytic efficiency (V max /K m ) of CYP1B1 in metabolizing PhIP to its promutagenic metabolite N-hydroxy-PhIP (7). Levels of CYP1A2 and CYP1A1 are thus 6-phenylimidazo[4,5-b]pyridine. The level of PhIP-DNA adducts in the PhIP-DNA standard (22) was determined to be likely to have more influence than CYP1B1 on N-hydroxylated heterocyclic amine levels in BPH tissues. Close agreement has 10.78 Ϯ 2.34 adducts per 10 8 nucleotides (range 7.86-12.32, n ϭ 4 determinations). As the adduct level was estimated by been found between CYP1A2 mRNA and protein levels in human liver (33, 34) . Immunohistochemical analysis of prostate 3 H incorporation to be 350 adducts per 10 8 nucleotides (22) , the efficiency of labelling is calculated to be 3%. The levels tissue sections could confirm translation of CYP1A2 mRNA and would give an indication of CYP1A2 protein localization of experimentally induced PhIP-DNA adduct formation in prostatic tissues in our study can therefore be estimated to be and expression levels. The CYP1A2 gene is polymorphic (35-37) but the functional consequences of this are unknown.30-fold higher than the reported values (e.g. mean levels of 90 adducts per 10 8 nucleotides in tissues incubated with PhIP CYP1A1 is also expressed and is inducible in mammary epithelial cells (8, 38) , and is likely to contribute significantly at 500 µM).
to the metabolic activation of heterocyclic and aromatic amines human mammary epithelial cells (28) , where mean levels of PhIP-DNA adducts after treatment of human mammary and PAHs in human mammary and prostate tissues. Further study is required to elucidate the contribution of various CYP epithelial cells with N-hydroxy PhIP were 30-600 times higher than after treatment with PhIP. Wang et al. (45) reported PhIPenzymes to the metabolic activation of these carcinogens, including as yet unidentified CYP isoforms that may be DNA adduct formation from N-hydroxy PhIP in prostate epithelial cells after incubation at 10 µM for 2 h (compared with expressed specifically in the prostate. It is therefore appropriate to point out that the CYP enzymes involved in the metabolic 22 h at 20 µM in the current study), although the levels of adduct formation were an order of magnitude lower than those observed activation of these compounds in the prostate remain to be conclusively identified.
in our experiments. A study of the metabolites of orally administered [ 14 C]PhIP CYP1A1 is inducible in human mammary epithelial cells and in the rat prostate gland by the aryl hydrocarbon receptor in plasma from colon cancer patients identified the parent compound as the major radioactive species in three out of ligand 3-methylcholanthrene (39). Larsen et al. (38) reported a 21-fold variation of CYP1A1 mRNA levels in human five patients (47). Systemic circulation of PhIP in healthy individuals would present the parent compound for local mammary epithelial cells in seven individuals, whereas CYP1B1 expression varied by only 2.5-fold. CYP1A1 and metabolic activation to DNA-binding derivatives in the prostate. Our results in prostate have shown that N-hydroxy PhIP is a CYP1B1 genes are not co-ordinately expressed in chorion carcinoma cell lines (40), but it is difficult to establish from much better substrate for metabolic activation than the parent compound in prostate tissues. N-hydroxy PhIP was not our results whether this is also the case in prostate tissues: although the highest levels of CYP1A1 and CYP1B1 expression detectable in human plasma after oral administration of the parent heterocyclic amine (47), and hepatic amine reductases are in the same individuals, there is much greater variation of CYP1A1 expression (6-fold) compared with CYP1B1 (2-fold).
have been shown to be able to reduce the N-hydroxylated derivatives of heterocyclic and aromatic amines back to their PhIP is a prostate carcinogen in the F344 rat when administered orally at 400 p.p.m. for 52 weeks, and also causes respective parent compounds (48) . Also, after incubation of another heterocyclic amine, 2-amino-3,8-dimethylimidazo atypical hyperplasias in both lobes (41). PhIP-DNA adducts are detectable in rat prostate tissues after ingestion, and this [4,5-f]quinoxaline (MeIQx), in human hepatocytes, only the N-hydroxy-MeIQx glucuronide was formed, and not the free compound is suspected of being a prostate carcinogen in man (41). The major site of reaction in DNA of metabolically N-hydroxy metabolite (49) . Together with the data presented in this paper, these studies (47-49) represent accumulating weight activated heterocyclic amines is the C8 atom of guanine (15,42). PhIP concentrations in the tissue incubation experiof evidence to support the notion that metabolic activation occurs at the target site (i.e. the prostate). ments are four to five orders of magnitude higher than plasma levels of PhIP after a fried hamburger meal (based on ingestion Some epidemiological studies suggest a positive association between occupational exposures to PAHs and increased risk of 2 µg PhIP by a 70 kg male with a volume of distribution of 60/dm 3 ). However, men eating cooked meats are chronically of prostate cancer (50-52). Non-occupational exposure to PAHs is mainly in the diet (53) and by inhalation of air-borne exposed to PhIP, other heterocyclic amines and PAHs over the period of a lifetime (~75 years), indicating an opportunity to pollution and tobacco-smoke. In this study, the PAH B[a]P was metabolically activated in prostatic tissues. The inhibition accumulate DNA adduct-induced mutations at much lower levels of exposure. Demonstration of the presence of PhIPof B[a]P adduct formation by α-naphthoflavone, an inhibitor of the CYP1 family (54) , indicates that CYP1 enzymes are at DNA adducts in the prostate in vivo would strengthen the hypothesis that cooked meat consumption leads to preleast partially responsible for the metabolic activation of PAHs in human prostatic tissue. mutagenic lesions in this tissue, possibly leading to carcinogenesis; meat consumption increases colon cancer risk (43), In summary, our results show expression of CYP1A2, CYP1A1 and CYP1B1 in BPH tissues. We also report the and PhIP-DNA adducts have been detected in human colon tissue (44). metabolic activation of compounds suspected of being prostate carcinogens in these tissues. These results are consistent with NATs and SULTs play a major role in the activation of heterocyclic amines in the breast (J.A. Williams 
